Znaczenie komórek macierzystych w inicjacji nowotworów wątroby u szczurów

• Autorzy: Wojcik M. , Giorgi M. , Bobowiec R.

Warianty tytułu

EN

Significance of stem cells in hepatocarcinogenesis in rats

• Języki publikacji: PL

Abstrakty

EN

Hepatic oval cells (OC) are considered to be the stem cells of the liver and have been linked to the development of hepatocellular carcinoma HCC, one of the most lethal cancers. The objective of this study was to analyse the proliferative response of OC obtained from rats receiving diethylnisamine DEN. In addition, we investigated the effects of resveratrol (Res) on the proliferation and oxidative markers of OC in vitro. OC isolated by in situ collagenase liver perfusion methods were treated with different concentrations of Res for 24, 48 and 72 hours. At the end of these periods the proliferative activity of OC, the release of superoxide anion by OC and the medium concentration of malonylodialdehyd were analyzed . The proliferation of OC cultured without Res increased from IP = 0.945 ± 0.02 to IP = 1.525 ± 0.031 after 24 and 72 hours respectively. A marked (p ≤ 0.05) inhibition of OC proliferation was observed in the presence of 1.0 µM, 25 µM and 100 µM of Res. A significant decrease in the release of O₂⁻. by OC, observed throughout the experimental period, was attributed to the presence of 25 µM of Res. Exposition of OC to 100 µM of Res inhibited the release of O₂⁻. only after 48 and 72 hours of incubation. The presence of 25 µM of Res resulted in the depletion of MDA level, which did not exceed 0.19±0.009 nM. Proliferative activity of OC isolated from carcinogenic rats intensified throughout the culture period. When subjected to the carcinogenic effect of DEN, Res exerts anti-proliferative influence on OC. Moreover, our results provide evidence that Res attenuates oxidative stress during hepatocarcinogenesis.

Słowa kluczowe

PL

szczury; nowotwory watroby; rak watrobowokomorkowy; komorki macierzyste; komorki owalne; aktywnosc proliferacyjna; resweratrol; hamowanie proliferacji; dzialanie przeciwutleniajace

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2012
• Tom: 68
• Numer: 09
• Opis fizyczny: s.562-565,rys.,tab.,bibliogr.

Twórcy

autor

Wojcik M.

• Zakład Patofizjologii, Katedra Przedklinicznych Nauk Weterynaryjnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, u.Akademicka12, 20-033 Lublin

autor

Giorgi M.

autor

Bobowiec R.

Bibliografia

• 1.Bishayee A., Barnes K. F., Bhatia D., Darves A. S., Carrol R. T.: Resveratrol supress oxidative stress and inflamatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. 2010, 3, 753-763.
• 2.Bishayee A., Dhir N.: Resveratrol-mediated chemoprevention of diethylnitrosamine-initited hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem. Biol. Interact. 2009, 179, 131-144.
• 3.Bergero D., Nervy J.: Hepatic diseases in horses. J. Anim. Physiol. Anim. Nutr. 2008, 92, 345-355.
• 4.Fukui Y., Sato J., Sato R., Yasuda J., Naito Y.: Canine serum thermostable alkaline phosphatase isoenzyme from a dog with hepatocellular carcinoma. J. Vet. Med. Sci. 2006, 68, 1129-1132.
• 5.Laconi E.: Differential growth: From carcionogenesis to liver repopulation. Am. J. Pathol. 2000, 156, 389-392.
• 6.Lee E., Shin M., Yoon S., Moon J.: Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Arch. Pharm. Res. 2010, 33, 925-932.
• 7.Libbrecht L., Roskams T.: Hepatic progenitor cells in human liver diseases. Cell. Dev. Biol. 2002, 13, 389-396.
• 8.Lowes K. N., Croager E. J., Olynyk J. K., Abraham L. J., Yeoh G. C.: Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J. Gastroenterol. Hepatol. 2003, 18, 4-12.
• 9.Nagy P., Bisgaard H. C., Santoni-Rugiu E., Thorgeirrson S. N.: In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (Oval) cells after administration of 2-Acetylaminofluorene. Hepatology 1996, 23, 71-79.
• 10.Oh S. I., Ieather M., Iatch I., Petersen B. E.: Hepatic oval "stem" cell in liver regeneration. Cell. Dev. Biol. 2002, 13, 405-409.
• 11.Petersen B. E.: Hepatic stem cells: coming full circle. Blood. Cell. Mol. Dis. 2001, 27, 590-600.
• 12.Routhuizen J., Van den Ingh T. S.: Hepatitis in dog, a review. Tjidskr. Diergenees. 1998, 15, 246-252.
• 13.Sell S.: Cellular origin of hepatocellular carcinomas. Cell. Dev. Biol. 2002, 13, 419-424.
• 14.Shiga A., Shirota K., Enomoto M.: Combined hepatocellular and cholangiocellular carcinoma in a dog. J. Vet. Med. Sci. 2001, 63, 483-486.
• 15.Wang Ch., Prasain J., Barnes S.: Review of the methods used in the determination of phytoestrogens. J. Chromatogr. 2002, 777, 3-28.
• 16.Wessely-Szponder J., Szponder T.: Comparison of the effects of two anaesthetic combinations in rabbits on some neutrophil functions in vitro. World Rabbit Sci. 2010, 18, 169-177.
• 17.Wójcik M., Bobowiec R., Martelli F.: Effect of carotenoids on in vitro proliferation and differentiation of oval cells during neoplastic and non-neoplastic injures in rats. J. Physiol. Pharmacol. 2008, 59, Supl. 2, 203-213.
• 18.Wójcik M., Kosior-Korzecka U., Bobowiec R.: Cytoprotective action of 17β-oestradiol against iron-induced hepatic oxidative stress in vitro. Bull. Vet. Inst. Pulawy 2010, 54, 259-263.
• 19.Zimmermann A.: Liver regeneration. The emergence of new pathways. Med. Sci. Monit. 2002, 8, 53-63.